30044-78-1
30044-78-1 結(jié)構(gòu)式
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2025/02/08 | HY-N6894A | 鹽酸異黃連堿 Pseudocoptisine chloride | 30044-78-1 | 1 mg | 800元 |
| 2025/02/08 | HY-N6894A | 鹽酸異黃連堿 Pseudocoptisine chloride | 30044-78-1 | 5mg | 2000元 |
| 2025/02/08 | HY-N6894A | 鹽酸異黃連堿 Pseudocoptisine chloride | 30044-78-1 | 10mg | 3000元 |
常見問題列表
Pseudocoptisine (0, 60, 90 μM; 1 hour) dose-dependently inhibited LPS-induced NO production in RAW264.7 cells.
Pseudocoptisine (30-90 μM; 1 hour; RAW264.7 cells) significantly reduces the LPS-induced TNF-α and IL-6 production and their mRNA expressions.
Pseudocoptisine acetate reduces levels of the pro-inflammatory mediators, such as, iNOS, COX-2, TNF-alpha, and IL-6 through the inhibition of NF-kappaB activation via the suppression of ERK and p38 phosphorylation in RAW 264.7 cells.
The anti-amnesic activities of Pseudocoptisine in mice on the learning and memory impairments induced by scopolamine (1.0 mg/kg, i.p.) are examined. Pseudocoptisine (2.0 mg/kg, p.o.) significantly reverses cognitive impairments in mice by passive avoidance test.